Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-09-10
著者
-
谷脇 雅文
高知工科大学工学部
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Nakamura S
Department Of Pathology Nagoya University School Of Medicine
-
Nakamura Shigeo
国立がんセンター中央病院 血液内科
-
Nakamura Shigeo
群馬県立がんセンター 病理検査
-
TAWARA Masayuki
Nagasaki CML Study Group
-
Ando Kiyoshi
Division of Hematology and Oncology, Tokai University School of Medicine
-
Nakagawa Shun-ichi
鈴鹿中央総合病院(厚生連)
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Takahashi Masatomo
Division Of Hematology And Oncology Department Of Internal Medicine St. Marianna University School O
-
Takahashi Masatomo
聖マリアンナ医科大学 血液･腫瘍内科
-
Matsushima Takafumi
Department Of Hematology St. Marianna University School Of Medicine
-
谷脇 雅文
Department Of Environmental Systems Engineering Kochi University Of Technology
-
Kobayashi Y
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Usubuchi Noriko
国立がんセンター中央病院
-
Usubuchi Noriko
Hematology And Oncology Division National Cancer Center Hospital East
-
Tateishi Ukihide
Department Of Radiology Yokohama City University Graduated School Of Medicine
-
Tateishi Ukihide
Yokohama City Univ. Kanagawa Jpn
-
Tateishi Ukihide
Department Of Radiology Yokohama City University School Of Medicine
-
Tateishi Ukihide
Department Of Radiology Yokohama City University Hospital Graduate School Of Medicine
-
Tateishi Ukihide
国立がんセンター中央病院 放射線診断部
-
Takayama K
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tsukasaki Kunihiro
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Hotta Tomomitsu
National Hospital Organization Nagoya Medical Center
-
Hotta Tomomitsu
国立がんセンター中央病院 血液内科
-
Hotta Tomomitsu
東海大学 医学研究科血液腫瘍内科
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center Hospital
-
ANDO Kiyoshi
Tokai University
-
Ogawa Yoshiaki
東海大学 医学部血液･腫瘍内科
-
Ogawa Yoshiaki
Department Of Hematology And Oncology Tokai University School Of Medicine
-
Ogawa Yoshiaki
東海大学 医学部内科学
-
Kagami Yoshitoyo
東海大学 医学部血液･腫瘍内科
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
Kagami Yoshitoyo
東京大学医科学研究所ヒトゲノム解析センター
-
Uoshima Nobuhiko
京都府立医科大学 血液･腫瘍内科学
-
Uoshima Nobuhiko
Matsushita Memorial Hospital Moriguchi Jpn
-
Uoshima Nobuhiko
1st Department Of Internal Medicine Kyoto Prefectureal University Of Medicine
-
Taniwaki Masafumi
国立がんセンター中央病院 血液内科
-
Taniwaki Masafumi
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Okamoto Shinichiro
慶応義塾大学 医学部内科学血液研究室
-
Tsuchida Masahiro
産業医科大学 小児科学
-
Usui Noriko
東京慈恵会医科大学附属病院 中央検査部
-
Usui N
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
Tanimoto M
Blood Transfusion Division Department Of Internal Medicine Ii Okayama University Graduate School Of
-
Tanimoto Mitsune
Okayama Univ. Hospital Okayama Jpn
-
Tanimoto Mitsune
岡山大学 医歯総研究 第2内科
-
Okamoto Shin-ichiro
国立がんセンター中央病院 血液内科
-
Ohnishi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
AMAGASAKI Taro
Novartis Pharma Japan
-
TAKEYAMA Kunihiko
National Cancer Center Hospital
-
Yamamoto Kazuhito
愛知県がんセンター中央病院 血液･細胞療法部
-
Kanakura Yuzuru
大阪大学 医学系研究科心臓血管外科
-
Asaoku Hideki
Clinical Laboratory Hiroshima Red Cross Hospital Atomic-bomb Survivors Hospital
-
Iwanaga Masako
Nagasaki Univ. Graduate School Of Biomedical Sci. Nagasaki Jpn
-
Iwanaga Masako
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Tsubaki Kazuo
Third Department Of Internal Medicine Kinki University School Of Medicine
-
Tsubaki Kazuo
浜松医科大学 第3内科
-
Tsubaki Kazuo
近畿大学 産婦人科
-
Usui N
Jikei University Hospital
-
Kamiya Yoshikazu
Department Of Hematology Meitetsu Hospital
-
Kamiya Yoshikazu
愛知がんセンター 血液･細胞療法部
-
Tomonaga Masao
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Hotta Tomomitsu
Department Of Hematology Molecular Medicine Unit Atomic Disease Institute Nagasaki University Gradua
-
Hata Tomoko
Nagasaki University
-
Hata Tomoko
Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University G
-
Tanimoto Mitsune
名古屋大学 第1内科
-
Kawase Yoshiaki
Department Of Internal Medicine Japanese Red Cross Nagoya First Hospital
-
Odagiri Keiichi
Department Of Medicine Hamamatsu Red Cross Hospital
-
Tomonaga Masao
Department Of Hematology Atomic Bomb Disease Institute Nagasaki University School Of Medicine
-
Takeshita A
The Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Nakamura Shigeo
Department Of Pathology Nagoya University Graduate School Of Medicine
-
Uike Naokuni
Department Of Hemato-oncology Kyushu Cancer Center
-
Ozawa K
Division Of Genetic Therapeutics Center For Molecular Medicine Jichi Medical University
-
Ohshima Koichi
First Department Of Pathology Fukuoka University
-
Tobinai Kensei
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Ohashi Haruhiko
Clinical Research Center For Blood Disease National Hospital Organization Nagoya Medical Center
-
Ohashi Haruhiko
Clinical Research Center For Blood Diseases National Hospital Organization Nagoya Medical Center
-
Ohashi Haruhiko
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Taniwaki Masafumi
Third Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Taniwaki Masafumi
Department Of Molecular Hematology And Oncology Kyoto Prefectural University Of Medicine Graduate Sc
-
Nakao Shinji
Department Of Cellular Transplantation Biology Kanazawa University Graduate School Of Medical Scienc
-
ISHIKAWA Takayuki
Kyoto University
-
Kobayashi Yukio
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Okamoto Shin-ichiro
Division Of Hematology Department Of Medicine Keio University School Of Medicine
-
Kanamaru Akihisa
Division Of Hematology Nephrology And Rheumatology Department Of Internal Medicine Kinki University
-
Tsukasaki K
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Disease Institute Nagasaki University Gradua
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University
-
Usui Noriko
Jikei Univ. Hospital Tokyo Jpn
-
Usui Noriko
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Oshimi Kazuo
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Taniwaki Masafumi
Department Of Hematology/oncology Kyoto Prefectural University Of Medicine
-
Hata Tomoko
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Akiyama Hideki
Hematology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Akiyama H
Tokyo Metropolitan Komagome Hospital Tokyo Jpn
-
Akiyama Hideki
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Akiyama Hideki
Department Of Civil And Ocean Engineering Faculty Of Engineering Ehime University
-
Tomita Akihiro
Department Of Chemical Engineering Himeji Institute Of Technology
-
Tomita Akihiro
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Ogura M
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Katayama Yoshio
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Kinoshita Tomohiro
Mie University
-
Katayama Yoshio
Hematology/oncology Department Of Medicine Kobe University Graduate School Of Medicine
-
Okamoto Shinichiro
Division Of Hematology Department Of Internal Medicane Keio University School Of Medicine
-
Ogura Michinori
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Kagami Yoshitoyo
Department Of Pathology School Of Medicine Kurume University
-
Ohnishi Kazunori
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Ohyashiki Kazuma
First Deparmtne Of Internal Medicine Tokyo Medical University
-
Nakamura S
Department Of Anatomic And Molecular Pathology Aichi Cancer Center Hospital
-
Kikuchi Ako
Tokai University
-
Ohhashi Kyoichi
Department Of Clinical Pharmacology And Therapeutics Hamamatsu University School Of Medicine
-
Takeshita Akihiro
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ozawa K
Division Of Hematology Department Of Medicine Jichi Medical University
-
Usui Noriko
Division Of Oncology & Hematology Department Of Internal Medicine The Jikei University School Of
-
Kawai Yasukazu
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Katayama Yoshio
Second Department Of Internal Medicine Okayama University Medical School
-
Tanimoto Mitsune
Okayama Univ. Graduate School Of Medicine Okayama Jpn
-
Usui Noriko
Division Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Yano Kunio
県西部浜松医療センター
-
Kimura Yukihiko
First Department Of Internal Medicine Tokyo Medical College
-
Asaoku Hideki
Internal Medicine Hiroshima Red Cross Hospital
-
Takeshita Akihiro
Hamamatsu Univ. School Of Medicine Shizuoka Jpn
-
Hotta Tomomitsu
Nagoya Medical Center Nagoya Jpn
-
Ohashi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
Cancer Center Hamamatsu University School Of Medicine
-
Ogura Michinori
Department Of Hematology And Chemotherapy Aichi Cancer Center
-
Kimura Yoshizo
Department Of Pathology School Of Medicine Kurume University
-
Ogawa Yoshiaki
Division Of Hematology/oncology Department Of Internal Medicine Tokai University School Of Medicine
-
Kanamaru Akihisa
Division Of Hematology And Oncology Department Of Medicine Tokai University School Of Medicine
-
Tabata Masahiro
The Department Of Internal Medicine Ii Okayama University Medical School
-
Ozawa Keiya
Division Of Genetic Therapeutics Center For Molecular Medicine Department Of Medicine Jichi Medical
-
Nakamura Satoko
Department Of Pathology Okayama University Graduate School Of Medicine Dentistry And Pharmaceutical
-
Tsukasaki Kunihiro
The Department Of Haematology Of Atomic Disease Institute Nagasaki University School Of Medicine
-
Mori Shinichiro
Department Of Hematology And Oncology Kansai Medical University Hirakata Hospital
-
Taniwaki Masafumi
Division Of Hematology And Oncology Department Of Internal Medicine St. Marianna University School O
-
Ohnishi Kazunori
Shikoku National Hospital Matsuyama Jpn
-
Ishikawa Takayuki
Department Of Animal Sciences Nihon University
-
Nakamura Shigeo
Department Of Pathology Nagoya University
-
Tamura Amane
Hamamatsu Univ. School Of Medicine Shizuoka Jpn
-
Uchida Toshiki
Department Of Hematology And Oncology Nagoya Daini Red Cross Hospital
-
Ozawa Keiya
Division Of Genetic Therapeutics Center For Molecular Medicine
-
Ogawa Yoshiaki
Division Of Hematology And Oncology Department Of Internal Medicine Tokai University School Of Medicine
-
Amano Hiroki
Department Of Public Health Shimane University Faculty Of Medicine
-
TATEISHI Ukihide
Department of Radiology, Yokohama City University Graduate School of Medicine
-
Ozawa Keiya
Division of Cell Therapy, Jichi Medical University Hospital, Shimotsuke
-
OKAMOTO Shin-ichiro
Keio University Hospital
-
HOTTA TOMOMITSU
National Cancer Center
関連論文
- 特集「顕微鏡法による材料開発のための微細構造研究最前線(8)-照射効果の解明と耐照射材料および新素材開発をめざして-」の企画にあたって
- イオン注入法によるFe及びCu超微粒子形成とGMR特性(第17回「電磁力関連のダイナミクス」シンポジウム)
- 24pYF-11 GaSb, InSbの電子線照射効果(格子欠陥・ナノ構造(半導体),領域10,誘電体,格子欠陥,X線・粒子線,フォノン物性)
- 点欠陥の自己組織化的挙動を利用した微細構造形成法
- イオン照射で導入される点欠陥を利用したナノセル構造の形成
- イオン照射によって導入された点欠陥によるセル構造の形成
- イオン照射による半導体微細セル構造の自己組織化形成
- 低温でのSnイオン注入によってGaSb表面に形成される特異な欠陥構造とその形成機構
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Castleman's Disease of the Retroperitoneum : With Special Reference to IgG4-Related Disorder
- Use of hydroxy-methyl-glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignancies
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- Allogeneic Peripheral Blood Stem Cell Transplantation in 23 Adult Patients With Hematologic Malignancies: A Single-Center Experience
- Granulocyte Colony-Stimulating Factor and Lineage-Independent Modulation of VLA-4 Expression on Circulating CD34^+ Cells
- Replating potential of colony-forming units of granulocytes/macrophages (CFE-GM) expanded ex vivo by stem cell factor, interleukin (IL)-3, IL-6, granulocyte colony-stimulating factor, erythropoietin with or without thrombopoietin
- Trisomy 12 and t(14;18) in B-cell chronic lymphocytic leukemia
- G-CSF-induced mobilization of peripheral blood stem cells for allografting: comparative study of daily single versus divided dose of G-CSF
- Androgen therapy in combination with granulocyte colony-stimulating factor and erythropoietin in a patient with refractory anemia
- Predominant Infiltration of Monocytes in Chronic Graft-Versus-Host Disease
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- AuCu合金の相転移と熱膨張挙動
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Gastric low-grade B-cell MALT lymphoma : treatment, response, and genetic alteration
- Clinicopathologic Comparison between the API2-MALT1 Chimeric Transcriptpositive and -negative Gastric low-grade B-Cell Lymphoma of Mucosa-associated Lymphoid Tissue Type
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Expression profiling analysis of the CD5^+ diffuse large B-cell lymphoma subgroup : Development of a CD5 signature
- Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
- Senile Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders : a Mini Review
- CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Follicular lymphoma frequently originates in the salivary gland
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- "Follicular Variant" of Hyaline-vascular Type of Castleman's Disease : Histopathological and Immunohistochemical Study of 11 Cases
- Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- Estimation of the relationship between caspase-3 expression and clinical outcome of Burkitt's and Burkitt-like lymphoma
- Double High-dose Chemotherapy Supported by Autologous Transplantation of Peripheral Blood Stem Cells for Treatment of an Elderly Patient with Small-Cell Lung Cancer
- 白滝鉱山が地域にもたらしたもの
- 「わが国の鉱業の過去, 現在そして未来」の企画にあたって
- 小特集の企画にあたって
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia
- Autoimmune hemolytic anemia in allergic granulomatous angitis (Churg-Strauss syndrome)
- Primary cutaneous T-cell lymphoma of unspecified type with cytotoxic phenotype : Clinicopathological analysis of 27 patients
- Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders : Special references to lymphomas surrounding this newly recognized clinicopathologic disease
- Post-transplant plasmacytoma without Epstein-Barr virus infection occurring rapidly after unrelated allogeneic bone marrow transplantation
- Void Formation and Structure Change Induced by Heavy Ion Irradiation in GaSb and InSb
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Age-related EBV-associated B-cell lymphoproliferative disorders : Diagnostic approach to a newly recognized clinicopathological entity
- Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection
- Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Atypical Lymphoplasmacytic and Immunoblastic Proliferation of Autoimmune Disease : Clinicopathologic and Immunohistochemical Study of 9 Cases
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma : a single institute experience
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Formation of Defect Structure on Ge Surface by Ion Irradiation at Controlled Substrate Temperature
- Etanercept overcomes P-glycoprotein-induced drug resistance in lymphocytes of patients with intractable rheumatoid arthritis
- Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis
- Contrast-enhanced endoscopic ultrasonography (CE-EUS) findings in adrenal metastasis from renal cell carcinoma
- Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
- Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
- Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissues
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- ABO blood group alleles and the risk of pancreatic cancer in a Japanese population
- Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : the AEGIS Clinical Trial
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- Association between insulin-like growth factor-1 polymorphisms and stomach cancer risk in a Japanese population
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
- A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
- M2 Macrophage/Microglial Cells Induce Activation of Stat3 in Primary Central Nervous System Lymphoma
- Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Intravascular B-cell lymphoma with hypercalcemia as the initial presentation
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia : continuity from carrier status to smoldering ATL
- Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma
- Late effect of Atomic bomb radiation on myeloid disorders : leukemia and myelodysplastic syndromes
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95